GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lifecome Biochemistry Co Ltd (SZSE:002868) » Definitions » Interest Expense

Lifecome Biochemistry Co (SZSE:002868) Interest Expense : ¥-49.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Lifecome Biochemistry Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Lifecome Biochemistry Co's interest expense for the three months ended in Mar. 2024 was ¥ -15.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-49.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Lifecome Biochemistry Co's Operating Income for the three months ended in Mar. 2024 was ¥ -10.9 Mil. Lifecome Biochemistry Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -15.5 Mil. Lifecome Biochemistry Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lifecome Biochemistry Co Interest Expense Historical Data

The historical data trend for Lifecome Biochemistry Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecome Biochemistry Co Interest Expense Chart

Lifecome Biochemistry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.13 -0.98 -2.81 -16.22 -37.10

Lifecome Biochemistry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.61 -7.95 -2.84 -22.70 -15.55

Lifecome Biochemistry Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-49.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecome Biochemistry Co  (SZSE:002868) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lifecome Biochemistry Co's Interest Expense for the three months ended in Mar. 2024 was ¥-15.5 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥-10.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥540.4 Mil.

Lifecome Biochemistry Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Lifecome Biochemistry Co did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Lifecome Biochemistry Co (SZSE:002868) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lifecome Biochemistry Co Ltd (SZSE:002868) » Definitions » Interest Expense
Comparable Companies
SHSE:688670 SHSE:688136 BJSE:430047 SHSE:688068 SZSE:300381 SZSE:300238 SZSE:000710 SHSE:688137 SZSE:301166 SHSE:688221 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No.19, Nanpu Ecological Industrial Park, Pucheng, Fujian, CHN, 353400
Website
http://www.pclifecome.com
Lifecome Biochemistry Co Ltd is a biopharmaceutical company which is engaged in the microbial pharmacy in China. Its main products include Bacitracin Zinc products (Bacitracin Zinc Premix, Bacitracin Zinc API), Colistin Sulfate products (Colistin Sulfate Premix, Colistin Sulfate API), Probiotics products (Bacillus Subtilis, Bacillus Licheniformis), Bacitracin Methylene Disalicylate products, biological preservatives: and Natamycin products.
Executives
Lou Li Jun Supervisors
Huang Hui Executives
Bao Zhong Shou Executives
Feng Zhen Wu Supervisors
Li Jun Hui Executives
Lai Tan Ping Directors, executives
Xu Chun Lin Director
Lai Jian Ping Directors, executives

Lifecome Biochemistry Co (SZSE:002868) Headlines

No Headlines